| http://www.w3.org/ns/prov#value | - However, a vast and increasing number of siRNAs targeting important molecular pathways, such as those involved in apoptosis, proliferation, cell invasion/migration, angiogenesis, and metabolism, has been studied and could represent good candidates for malignant glioma treatment (see [67] as review).One particularly important drawback for the clinical development of siRNA therapeutics is the necess
|
